Ciprofloxacin

Ciprofloxacin

SCHEMBL2900

O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

gyrAgyrBparCparE

The experimentally established mechanism targets of Ciprofloxacin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 1.00
ALDH1A1 P00352 6/20 1.00
LMNA P02545 5/20 1.00
HPGD P15428 4/20 1.00
HSD17B10 Q99714 4/20 1.00
CYP1A2 P05177 1/20 1.00
TOP2A P11388 1/20 1.00
CYP2C9 P11712 1/20 1.00
TOP2B Q02880 1/20 1.00
MAPT P10636 1/20 0.73
HTT P42858 2/20 0.67
BRD4 O60885 1/20 0.67
TSHR P16473 1/20 0.67
CYP2J2 P51589 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67
PIK3CG P48736 7/20 0.62
PIK3CD O00329 5/20 0.62
PIK3R1 P27986 5/20 0.62
PIK3CA P42336 5/20 0.62
SMN1; SMN2 Q16637 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ciprofloxacin SCHEMBL2325956 1.00 KDM4E (1.00) KDM4EALDH1A1LMNAHPGDHSD17B10
Ciprofloxacin SCHEMBL29137332 1.00 KDM4E (1.00) KDM4EALDH1A1LMNAHPGDHSD17B10
Ciprofloxacin SCHEMBL4459712 1.00 KDM4E (1.00) KDM4EALDH1A1LMNAHPGDHSD17B10
Ciprofloxacin SCHEMBL345730 1.00 KDM4E (1.00) KDM4EALDH1A1LMNAHPGDHSD17B10
Ciprofloxacin SCHEMBL7994990 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10
Ciprofloxacin SCHEMBL2465661 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10
Ciprofloxacin SCHEMBL1973497 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10
Ciprofloxacin SCHEMBL21519294 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10
Ciprofloxacin SCHEMBL42310 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10
Ciprofloxacin SCHEMBL5618780 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 111480 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260145984-A1 EXPANDING TIP PLUGS AND METHOD OF USING AND MAKING THE SAME CORNING INCORPORATED (US) 2026-05-28 US claimed
EP-4113688-B1 SULFIDE SOLID ELECTROLYTE FOR ALL-SOLID SECONDARY BATTERY, METHOD OF PREPARING THE SAME, AND ALL-SOLID SECONDARY BATTERY INCLUDING THE SAME SAMSUNG SDI CO LTD (KR) 2026-05-27 EP claimed
EP-3802484-B1 DOPED METAL HALIDE PEROVSKITES WITH IMPROVED STABILITY AND SOLAR CELLS COMPRISING SAME GOVERNING COUNCIL UNIV TORONTO (CA) 2026-05-27 EP claimed
EP-4749288-A1 COMPOSITIONS FOR DETECTING, CHARACTERIZING, AND REMOVING A BIOFILM COSA Group GmbH (DE) 2026-05-27 EP claimed
CN-122076465-A Supported ternary heterojunction photocatalytic material and preparation method and application thereof 2026-05-26 CN claimed
CN-122075390-A Preparation and application of novel cow uterus injectant 2026-05-26 CN claimed
CN-122075719-A Neuraminidase-ROS dual-response nano-carrier as well as preparation method and application thereof 2026-05-26 CN claimed
CN-122076460-A Metal doped bismuth ferrite based perovskite composite material and preparation method and application thereof 2026-05-26 CN claimed
CN-122094963-A Cardioprotective lipids and methods of use 2026-05-26 CN claimed
WO-2026106551-A1 ANTIMICROBIAL PEPTIDE NANONETS AND METHODS OF USE THEREOF NATIONAL UNIVERSITY OF SINGAPORE (SG) 2026-05-21 WO claimed
WO-1986006630-A1 USE OF QUINOLONE DERIVATIVES FOR THE TREATMENT OF MYCOPLASMAL PNEUMONIA IN PIGS BEECHAM GROUP P.L.C. (GB) 1986-11-20 WO claimed
EP-0078362-B1 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-PIPERAZINO-QUINOLINE-3-CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS CONTAINING THEM BAYER AG (DE) 1986-10-22 EP claimed
EP-0187315-A2 Basic quinolonecarboxylic-acid preparations BAYER AG (DE) 1986-07-16 EP claimed
US-4599334-A 7-(3-aryl-1-piperazinyl)- and 7-(3-cyclohexyl-1-piperazinyl)-3-quinolonecarboxylic acid antibacterials BAYER AKTIENGESELLSCHAFT (DE) 1986-07-08 US claimed
US-4563459-A FUNGICIDES AND BACTERICIDES FOR AGRICULTURAL USE BAYER AKTIENGESELLSCHAFT (DE) 1986-01-07 US claimed
EP-0165474-A1 Immunostimulant agent BAYER AG (DE) 1985-12-27 EP claimed
EP-0138018-A2 Solutions of lactic acid salts of piperazinylquinolone and piperazinyl azaquinolonecarboxylic acids BAYER AG (DE) 1985-04-24 EP claimed
EP-0049355-B1 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-(naphthyridine or quinoline)-3-carboxylic acids, process for their preparation and pharmaceutical compositions containing them BAYER AG (DE) 1984-10-10 EP claimed
EP-0078362-A2 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazino-quinoline-3-carboxylic acids, process for their preparation and antibacterial agents containing them BAYER AG (DE) 1983-05-11 EP claimed
EP-0049355-A1 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-(naphthyridine or quinoline)-3-carboxylic acids, process for their preparation and pharmaceutical compositions containing them BAYER AG (DE) 1982-04-14 EP claimed